ERYP
$2.93
Erytech Pharma ADR
($.09)
(2.98%)
ERYP
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.59)
Revenue:  N/A
Monday
Sep 20
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ERYP reports earnings?
Beat
Meet
Miss

Where is ERYP's stock price going from here?
Up
Flat
Down
Stock chart of ERYP
Analysts
Summary of analysts' recommendations for ERYP
Score
Grade
Pivots
Resistance
$3.66
$3.53
$3.27

$3.14

Support
$2.88
$2.75
$2.49
Tweet
Growth
Description
Erytech Pharma S.A. operates as a biopharmaceutical company. It discovers and developes therapies for rare forms of cancer and orphan diseases. The company's product pipeline consists of eryaspase, erymethionase, eryminase, ERYZYME and ERYMMUNE which are in clinical stages. It operates primarily in France and the United States. Erytech Pharma S.A. is based in France.